Effect of modification of the 1-, 2-, and 6-positions of 9-beta-D-ribofuranosylpurine cyclic 3',5'-phosphate on the cyclic nucleotide specificity of adenosine cyclic 3',5'-phosphate- and guanosine cyclic 3',5'-phosphate-dependent protein kinases.
D000818:Animals; D001921:Brain / Q000201:enzymology; D002417:Cattle; D000242:Cyclic AMP / Q000031:analogs & derivatives* / Q000378:metabolism*; D006152:Cyclic GMP / Q000378:metabolism*; D004789:Enzyme Activation / Q000187:drug effects; D009132:Muscles / Q000201:enzymology; D008121:Nephropidae; D011494:Protein Kinases / Q000378:metabolism*; D013329:Structure-Activity Relationship; D013379:Substrate Specificity
C028539:9 beta-D-ribofuranosylpurine cyclic 3',5'-phosphate; D000242:Cyclic AMP; D011494:Protein Kinases; D006152:Cyclic GMP